ReviewAdvances in neurobiology2023

Monoamine Oxidase B (MAO-B): A Target for Rational Drug Development in Schizophrenia Using PET Imaging as an Example.

Kankana Nisha Aji et al.PubMed ↗Publisher ↗

No numbers read from the abstract.